FisclearFisclear

Financial Comparison

Divi's Laboratories Limited vs Dr. Reddy's Laboratories Limited

Click a ticker to view the full analysis.

DIVISLAB.NS vs

In short

Divi's Laboratories Limited is the more profitable of the two, keeping 24.5% of revenue as net profit against 12.8% for Dr. Reddy's Laboratories Limited. Divi's Laboratories Limited trades at the higher trailing P/E (85.0× vs 30.5× for Dr. Reddy's Laboratories Limited), so investors pay more for each dollar of its earnings. Fisclear flags 1 medium- or high-severity risk for Divi's Laboratories Limited and 0 for Dr. Reddy's Laboratories Limited.

Based on filings for periods ending 31 Mar 2026 (DIVISLAB.NS) and 31 Mar 2026 (DRREDDY.NS) · Updated

FisclearScore Comparison

DIVISLAB.NS55Fair
DRREDDY.NS55Fair
Quality
83
83
Efficiency+15
62
47
Value
26
26
Cashflow+24
39
63
Regime
55
55
Peers+7
58
51

FisclearScore is a quantitative model. DIVISLAB.NS shown solid · DRREDDY.NS shown dashed. Not financial advice.

MetricDIVISLAB.NSDRREDDY.NS
Price₹9,363.50₹1,188.00
Market Cap₹2.49T₹989.6B
P/E (TTM)85.0x30.5x
P/B14.8x2.6x
Beta0.230.25
Div Yield0.32%0.65%
Revenue (TTM)₹104.8B₹335.9B
Net Income₹25.7B₹42.9B
Gross Margin59.1%52.8%
Risk Flags1 flag1 flag
Full DIVISLAB.NS Report →Full DRREDDY.NS Report →

Related comparisons

Dr. Reddy's Laboratories vs Sun PharmaceuticalDIVISLAB.NS vs Sun PharmaceuticalCIPLA.NS vs Dr. Reddy's LaboratoriesAPOLLOHOSP.NS vs Dr. Reddy's LaboratoriesDr. Reddy's Laboratories vs TORNTPHARM.NSCIPLA.NS vs DIVISLAB.NS

Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.